Toggle light / dark theme

Special Report: Coronavirus Task Force Holds News Conference | NBC News (Live Stream)

The US is going to lockdown for 15 days to start.


Members of the Trump administration’s coronavirus task force, led by Vice President Mike Pence, hold a press briefing at the White House.
» Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC
» Watch more NBC video: http://bit.ly/MoreNBCNews

NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Nightly News, Meet the Press, Dateline, and the existing apps and digital extensions of these respective properties. We deliver the best in breaking news, live video coverage, original journalism and segments from your favorite NBC News Shows.

Connect with NBC News Online!
NBC News App: https://apps.nbcnews.com/mobile
Breaking News Alerts: https://link.nbcnews.com/join/5cj/breaking-news-signup?cid=s…lip_190621
Visit NBCNews. Com: http://nbcnews.to/ReadNBC
Find NBC News on Facebook: http://nbcnews.to/LikeNBC
Follow NBC News on Twitter: http://nbcnews.to/FollowNBC
Follow NBC News on Instagram: http://nbcnews.to/InstaNBC

Existing antibiotic found to take out the root cause of Lyme disease

Lyme disease is an infectious condition spread by ticks that affects as many as 300,000 people in the US every year, according to the Center for Disease Control and Prevention. Today’s treatment is largely effective in treating the infection, but a good portion of patients do not respond and go on to endure lingering symptoms. A new study has revealed that an already-approved antibiotic can completely eliminate the underlying bacteria that causes the disease in mice, offering new hope of a more comprehensive therapy for humans.

While the standard antibiotics used to treat Lyme disease do the job for the majority of patients, somewhere between 10 and 20 percent go on to experience its symptoms. These include muscle pain, fatigue, fever, headaches and heart problems. There are couple of theories for why this might be.

“Some researchers think this may be due to drug-tolerant bacteria living in the body and continuing to cause disease,” said study author Jayakumar Rajadas. “Others believe it’s an immune disorder caused by bacteria during the first exposure, which causes a perpetual inflammation condition. Whatever the cause, the pain for patients is still very real.”

US Military Scientists Hope To Have Coronavirus Therapeutic

A new approach would use RNA or DNA to help the body develop antibodies to the rapidly spreading illness.

A U.S. military research program that seeks a new way to boost a body’s immunity to viruses could change how governments and militaries prepare for pandemics — and might even arrive soon enough to help with the COVID −19 outbreak.

DARPAs Pandemic Prevention Platform isn’t looking to create a vaccine, which can take years to produce and weeks to take effect in the body. Rather, the goal is to identify the specific monoclonal antibodies that the body naturally produces when it encounters a virus, and then trick the body into producing the one that guards against a specific illness. That could serve as a temporary, months-long shield that can protect the individual from the pathogen until a vaccine can be brought online.

China May Have Identified Patient Zero in the Coronavirus Outbreak

And others in the research community, like this nuclear physicist at the Large Hadron Collider, are realizing how close they came to catching the virus.

The first COVID-19 case may have started as early as November 17. A good chunk of my reararch group, and our particular slice of the nuclear physics community, were literally in Wuhan until just a week before this. To think what could have been… https://www.scmp.com/news/china/society/article/3074991/coro…raced-back

— Dennis V. Perepelitsa (@dvperepelitsa) March 13, 2020

BREAKING! Coronavirus Research: Could Echinacea Act As A Prophylaxis Against The SARS-Cov-2 Coronavirus? More Research Warranted

Coronavirus Research : A recent study published on an open platform but has yet to be peer reviewed caught our eyes as it was strangely conducted by the prestigious Spiez Laboratory In Switzerland by a team of leading virologists and microbiologists, but what intrigued me was that why would a prestigious research centre like the Spiez laboratory that had enormous funds and had some of the leading specialist post a ‘half-baked’ research on an open platform?

Echinacea Flowers

The five hottest synthetic biology job markets in the world

Although the majority of the synthetic biology market is concentrated in North America and Europe, the synthetic biology landscape is growing worldwide — with some of the fastest growing areas developing outside of the United States. There are several hotspots — formed when innovation at one company or university lab sparks new spinoffs — that synthetic biology followers should pay close attention to in the coming months and years.

The United Kingdom and Ireland

Among non-US hotspots for synthetic biology, the United Kingdom stands out. While most US universities still lack programs in synthetic biology, they are not hard to come by in the UK. Imperial College London, the University of Warwick, Cambridge University, and the University of Edinburgh are all particularly noteworthy for the depth and breadth of synthetic biology research. And, OpenPlant, a joint initiative between the University of Cambridge, John Innes Centre, and the Earlham Institute, is advancing synthetic biology by engineering the next generation of DNA tools for “smart” crop breeding systems.

/* */